UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-10 | -0.01 | -0.01 |
| Q1 2022 | 2022-05-10 | -0.03 | -0.03 |
| Q4 2021 | 2022-03-08 | -0.01 | -0.01 |
| Q3 2021 | 2021-11-09 | 0.02 | 0.02 |
| Q2 2021 | 2021-08-10 | -0.03 | -0.03 |
| Q1 2021 | 2021-05-12 | 0.01 | 0.01 |
| Q4 2020 | 2021-03-15 | -0.07 | -0.07 |
| Q3 2020 | 2020-11-10 | 0.09 | 0.09 |
| Q2 2020 | 2020-08-11 | -0.10 | -0.10 |
| 2016-05-12 | Reiterated Rating | Canaccord Genuity | Hold | |
| 2015-11-09 | Reiterated Rating | Canaccord Genuity | Hold | $2.50 |
| 2015-08-12 | Reiterated Rating | Canaccord Genuity | Hold | $2.50 |
| 2015-05-19 | Reiterated Rating | Brean Capital | Buy | $6.00 to $4.50 |
| 2015-05-14 | Reiterated Rating | Canaccord Genuity | Hold | $4.00 |
| 2015-03-19 | Reiterated Rating | Canaccord Genuity | Hold | $4.00 |
| 2014-05-02 | Upgrade | Sidoti | Neutral to Buy | |
| 2013-11-12 | Boost Price Target | Brean Capital | Buy | $5.00 to $5.50 |
| 2012-02-23 | Resumed | Brean Murray | Buy | $8 |
| 2010-06-09 | Upgrade | Avondale | Mkt Perform to Mkt Outperform | $6.50 to $8 |
| 2009-10-16 | Initiated | Brean Murray | Buy | $13 |
| 2009-04-06 | Downgrade | AmTech Research | Buy to Neutral | |
| 2009-03-06 | Reiterated | AmTech Research | Buy | $14 to $11 |
| 2009-01-14 | Reiterated | Roth Capital | Hold | $9 to $8 |
| 2008-11-11 | Reiterated | Roth Capital | Hold | $11 to $9 |
| 2008-11-11 | Downgrade | Lazard Capital | Buy to Hold | |
| 2008-11-04 | Reiterated | Roth Capital | Hold | $16 to $11 |
| 2008-10-16 | Initiated | Needham | Hold | |
| 2008-08-12 | Reiterated | Roth Capital | Hold | $22 to $16 |
| 2008-06-26 | Reiterated | Roth Capital | Hold | $24 to $22 |
| 2008-05-07 | Reiterated | JMP Securities | Mkt Outperform | $22 to $26 |
| 2008-05-06 | Downgrade | Roth Capital | Buy to Hold | $24 |
| 2008-03-06 | Reiterated | JMP Securities | Mkt Outperform | $25 to $22 |
| 2008-03-06 | Reiterated | Deutsche Securities | Hold | $24 to $17 |
| 2008-03-06 | Reiterated | Canaccord Adams | Buy | $45 to $28 |
| 2008-03-06 | Reiterated | Avondale Partners | Mkt Perform | $23 to $18 |
| 2016-05-12 | Reiterated Rating | Canaccord Genuity | Hold | |
| 2015-11-09 | Reiterated Rating | Canaccord Genuity | Hold | $2.50 |
| 2015-08-12 | Reiterated Rating | Canaccord Genuity | Hold | $2.50 |
| 2015-05-19 | Reiterated Rating | Brean Capital | Buy | $6.00 to $4.50 |
| 2015-05-14 | Reiterated Rating | Canaccord Genuity | Hold | $4.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In FTEK 33 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| GRACE & WHITE INC /NY | 1.71M |
| RENAISSANCE TECHNOLOGIES LLC | 0.78M |
| Vanguard Group, Inc | 0.78M |
| BlackRock Institutional Trust Company, N.A. | 0.54M |
| BlackRock Inc. | 0.48M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.39M |
| US BANCORP \DE\ | 0.30M |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.29M |
| Marquette Asset Management Inc. | 0.13M |
| STATE STREET CORP | 96846 |
| KCG Holdings, Inc. | 49840 |
| BlackRock Fund Advisors | 47835 |
| NORTHERN TRUST CORP | 40157 |
| KILLEN GROUP INC | 40000 |
| Creative Planning | 27350 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| BAILEY BETTYE J | 12.83% (2929356) | FTEK / |
| BAILEY DOUGLAS G President, CEO & Chairman | 8.25% (1882878) | FTEK / |
| Bettye J. Bailey GRAT A-2015 u/a/d March 27, 2015 | 2.83% (647134) | FTEK / |
| ARNONE VINCENT J Executive Vice President | 1.97% (449407) | FTEK / |
| Puissant Robert E Executive Vice President | 0.39% (89320) | FTEK / |
| ZEITLER DENNIS L | 0.22% (50000) | FTEK / MSA / |
| Markowsky James J | 0.09% (20000) | FTEK / |
| SHAW THOMAS S | 0.09% (20000) | FTEK / |
| ESPINOSA MIGUEL | 0.07% (17000) | FTEK / |
| Collins David S Sr. Vice President | 0.04% (9809) | FTEK / |
UM